Exosomes - structure, biogenesis and biological role in non-small-cell lung cancer
- PMID: 25359529
- DOI: 10.1111/sji.12247
Exosomes - structure, biogenesis and biological role in non-small-cell lung cancer
Abstract
Many different cells produce and release membraneous microvesicles (MV) or exosomes into their microenvironment. Exosomes represent a specific subtype of secreted derived vesicles which are defined as homogenous vesicles of 30-100 nm lined by a lipid bilayer, which contain a specific set of proteins, lipids, and nucleic acids. There are clear evidences that they serve as important biological signals messengers and carriers in physiological as well as in pathological processes. Those derived from tumours (tumour-derived exosomes, TD-exosomes) function as protumourigenic factors that can mediate intercellular communication in the tumour microenvironment and also contribute to cancer progression. The main functions of exosomes in the cancer microenvironment include the following: promotion of primary cancer growth, stimulation of angiogenesis, activation of stromal fibroblasts, sculpting the cancer ECM, generation of a premetastatic niche and suppression of host immune response. Exosomes have recently emerged as potentially promising diagnostic and prognostic biomarkers in cancer and other diseases. This article is a summary of information about the structure and origin of exosomes and also indicates the importance of exosomes and microRNAs in lung cancer. The role of exosomes in NSCLC is little known, and its explanation requires thorough research.
© 2014 John Wiley & Sons Ltd.
Similar articles
-
Roles of exosomes in the carcinogenesis and clinical therapy of non-small cell lung cancer.Biomed Pharmacother. 2019 Mar;111:338-346. doi: 10.1016/j.biopha.2018.12.088. Epub 2018 Dec 25. Biomed Pharmacother. 2019. PMID: 30590322 Review.
-
The biology, function and clinical implications of exosomes in lung cancer.Cancer Lett. 2017 Oct 28;407:84-92. doi: 10.1016/j.canlet.2017.08.003. Epub 2017 Aug 12. Cancer Lett. 2017. PMID: 28807820 Review.
-
Tumor-cell-derived microvesicles as carriers of molecular information in cancer.Curr Opin Oncol. 2013 Jan;25(1):66-75. doi: 10.1097/CCO.0b013e32835b7c81. Curr Opin Oncol. 2013. PMID: 23165142 Review.
-
Syntenin-ALIX exosome biogenesis and budding into multivesicular bodies are controlled by ARF6 and PLD2.Nat Commun. 2014 Mar 18;5:3477. doi: 10.1038/ncomms4477. Nat Commun. 2014. PMID: 24637612
-
Tumor-derived exosomes as mediators of disease and potential diagnostic biomarkers.Cancer Biomark. 2010-2011;8(4-5):281-91. doi: 10.3233/CBM-2011-0211. Cancer Biomark. 2010. PMID: 22045359
Cited by
-
Mesenchymal Stromal Cell-Derived Extracellular Vesicles in Lung Diseases: Current Status and Perspectives.Front Cell Dev Biol. 2021 Feb 15;9:600711. doi: 10.3389/fcell.2021.600711. eCollection 2021. Front Cell Dev Biol. 2021. PMID: 33659247 Free PMC article. Review.
-
Serum exosomal miR-1269a serves as a diagnostic marker and plays an oncogenic role in non-small cell lung cancer.Thorac Cancer. 2020 Dec;11(12):3436-3447. doi: 10.1111/1759-7714.13644. Epub 2020 Oct 27. Thorac Cancer. 2020. PMID: 33107700 Free PMC article.
-
Phosphorylation-dependent proteome of Marcks in ependyma during aging and behavioral homeostasis in the mouse forebrain.Geroscience. 2022 Aug;44(4):2077-2094. doi: 10.1007/s11357-022-00517-3. Epub 2022 Jan 24. Geroscience. 2022. PMID: 35075585 Free PMC article.
-
Exosomes: A Key Piece in Asthmatic Inflammation.Int J Mol Sci. 2021 Jan 19;22(2):963. doi: 10.3390/ijms22020963. Int J Mol Sci. 2021. PMID: 33478047 Free PMC article. Review.
-
Exosomes as Therapeutic and Diagnostic Tools: Advances, Challenges, and Future Directions.Cell Biochem Biophys. 2025 Mar 24. doi: 10.1007/s12013-025-01730-5. Online ahead of print. Cell Biochem Biophys. 2025. PMID: 40122928 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical